CAV1 and pancreatic neoplasm: Furthermore, Hehlgans et al. (2009) identified Caveolin-1 and TAE226 as potential radiosensitisers (in radiotherapy doses of 0–6 Gy) for the pancreatic cancer cell line MiaPacCa2 in a spheroid system [51,52].